The FDA has granted Breakthrough Therapy Designation for oral infigratinib (BridgeBio Pharma), which is currently under development for children with achondroplasia, according to a press release from ...

In a recently-published study, results demonstrated that residence in low-income, low-food access neighborhoods in early life was linked to higher subsequent child body mass index (BMI) and higher ...

First-generation antihistamine prescriptions were linked to a 22% higher seizure risk in young children, especially those aged 6 to 24 months, according to recent findings. First-generation ...

Preadolescent sleep disturbances were linked to an increased risk of suicidal thoughts and behaviors in early adolescence, highlighting sleep as a key intervention target. Findings from a study ...

FDA approves neffy as first nasal spray to treat anaphylaxis ...

California's AB 899 mandates baby food manufacturers test for toxic metals like arsenic, cadmium, lead, and mercury, increasing transparency and safety. The law, effective January 2025, may influence ...

Adolescents exposed to multiple adversities or elevated maternal depression showed worse mental health outcomes and altered brain connectivity. Four childhood adversity profiles were identified: low, ...

The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing ...

The indication is supported by trial data showing three-fourths of successfully treated patients maintained clear skin through 1 year of a lebrikizumab regimen. The US Food and Drug Administration ...

A new study suggests an early AI-powered algorithm could help accurately identify common movements exhibited by children with autism spectrum disorder. A deep learning-based algorithm designed to ...

How do you address bone density concerns and spermatogenesis in a male patient with CPP?

What are common misconceptions regarding the timing of therapy initiation and discontinuation? What has research shown regarding outcomes for initiating therapy before age 7 years or discontinuing ...